Previous 10 | Next 10 |
Quorum Health (NYSE: QHC ) -53% . More news on: Quorum Health Corporation, Sasol Limited, Enable Midstream Partners, LP, Stocks on the move, Read more ...
It is an exciting time in biotech. It seems like the big challenges are within reach. Cancer, diabetes, infectious diseases. Not everything, not right away. There are still a lot of bald men, for example. And unfortunately, Alzheimer’s seems intractable. But for investors that can mea...
Big Lots (NYSE: BIG ) -35% on Q4 earnings . More news on: Big Lots, Inc., Tonix Pharmaceuticals Holding Corp., Celsion Corporation, Stocks on the move, , Read more ...
Anaplan (NYSE: PLAN ) -29% despite Q4 beat . More news on: Anaplan, Inc., Continental Resources, Inc., Nutanix, Inc., Stocks on the move, , Read more ...
The biotech sector has been one of the better stock market performers for some time now, and the trend continued in 2020 as well so far. One of the biotech stocks that deserve attention at this point is that of Genprex Inc ( NASDAQ: GNPX ) , which has emerged as the biggest biotech stock gai...
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced today that it closed its previously announc...
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, on Wednesday announced that it has entered into securities purchase agreements with institutional investors for the purchase and ...
Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...
Gene therapy developer Genprex ( GNPX -16.8% ) slumps on increased volume in early trade in reaction to its direct offering of 5M common shares to institutional investors at $3.50 per share yielding gross proceeds of ~$17.5M. More news on: Genprex, Inc., Healthcare stocks news, Stocks ...
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly cancers based upon a novel proprietary technology platform,...
News, Short Squeeze, Breakout and More Instantly...
Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be participating at two conferences during May. According to the announcement, Genprex CFO Ryan Confer will be presenting at the Sidoti Microcap...
Genprex to Present and Participate at Upcoming May Investor and Industry Conferences PR Newswire AUSTIN, Texas , May. 1, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developin...
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting PR Newswire Compelling Data Validates the Potential...